GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Helius Medical Technologies Inc (NAS:HSDT) » Definitions » Asset Turnover

Helius Medical Technologies (Helius Medical Technologies) Asset Turnover : 0.02 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Helius Medical Technologies Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Helius Medical Technologies's Revenue for the three months ended in Mar. 2024 was $0.14 Mil. Helius Medical Technologies's Total Assets for the quarter that ended in Mar. 2024 was $6.72 Mil. Therefore, Helius Medical Technologies's Asset Turnover for the quarter that ended in Mar. 2024 was 0.02.

Asset Turnover is linked to ROE % through Du Pont Formula. Helius Medical Technologies's annualized ROE % for the quarter that ended in Mar. 2024 was -464.21%. It is also linked to ROA % through Du Pont Formula. Helius Medical Technologies's annualized ROA % for the quarter that ended in Mar. 2024 was -149.66%.


Helius Medical Technologies Asset Turnover Historical Data

The historical data trend for Helius Medical Technologies's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helius Medical Technologies Asset Turnover Chart

Helius Medical Technologies Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.08 0.05 0.05 0.05

Helius Medical Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.02 0.02 0.02

Competitive Comparison of Helius Medical Technologies's Asset Turnover

For the Medical Devices subindustry, Helius Medical Technologies's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helius Medical Technologies's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Helius Medical Technologies's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Helius Medical Technologies's Asset Turnover falls into.



Helius Medical Technologies Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Helius Medical Technologies's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.644/( (17.287+7.692)/ 2 )
=0.644/12.4895
=0.05

Helius Medical Technologies's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0.135/( (7.692+5.757)/ 2 )
=0.135/6.7245
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Helius Medical Technologies  (NAS:HSDT) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Helius Medical Technologies's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-10.064/2.168
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-10.064 / 0.54)*(0.54 / 6.7245)*(6.7245/ 2.168)
=Net Margin %*Asset Turnover*Equity Multiplier
=-1863.7 %*0.0803*3.1017
=ROA %*Equity Multiplier
=-149.66 %*3.1017
=-464.21 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Helius Medical Technologies's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-10.064/6.7245
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-10.064 / 0.54)*(0.54 / 6.7245)
=Net Margin %*Asset Turnover
=-1863.7 %*0.0803
=-149.66 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Helius Medical Technologies Asset Turnover Related Terms

Thank you for viewing the detailed overview of Helius Medical Technologies's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Helius Medical Technologies (Helius Medical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
642 Newtown Yardley Road, Suite 100, Newtown, PA, USA, 18940
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Executives
Dane Andreeff director, 10 percent owner, officer: President and CEO C/O ANDREEFF EQUITY ADVISORS L.L.C., 140 E. ST. LUCIA LANE, SANTA ROSA BEACH FL 32459
Jeffrey S Mathiesen director, officer: CFO and Treasurer 43334 SEVEN MILE RD., SUITE 1000, NORTHVILLE MI 48167
Favit-van Pelt Antonella R. officer: Chief Medical Officer C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, NEWTOWN PA 18940
Paul Buckman director 12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402
Sherrie L Perkins director 5033 TANGLE LANE, HOUSTON TX 77056
Jennifer Laux officer: Chief Commercial Officer 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN PA 18940
Thomas E Griffin director C/O ENTELLUS MEDICAL, INC., 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Blane Walter director 500 OLDE WORTHINGTON ROAD, WESTERVILLE OH 43082
Edward M Straw director C/O ESTEE LAUDER COMPANIES, 767 FIFTH AVENUE, NEW YORK NY 10153
Joyce N Laviscount officer: See Remarks 100 ENDO BOULEVARD, CHADDS FORD PA 19317
Huaizheng Peng director HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Philippe Deschamps director, 10 percent owner, officer: President & CEO 105 BRADFORD RD, SUITE 420, WEXFORD PA 15090
Mitch E Tyler director HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Jonathan Sackier 10 percent owner, officer: Chief Medical Officer HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
A&b (hk) Co Ltd 10 percent owner 8/F BLDG A TONGFANG INFORMATION HARBOR, NO 11 LANGSHAN ROAD NANSHAN DISTRICT, SHENZHEN F4 518057

Helius Medical Technologies (Helius Medical Technologies) Headlines